GO:0032874 positive regulation of stress-activated MAPK cascade: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032874 describes any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
• The stress-activated MAPK cascade is a conserved signaling module that responds to environmental stressors such as osmotic shock, oxidative stress, and infection [1,4].
• Positive regulation of this cascade involves upstream kinases such as MKK3/6 and MKK4/7 that phosphorylate p38 and JNK, respectively [3,8].
• Dysregulation of stress-activated MAPK signaling is implicated in cancer, neurodegeneration, and inflammatory diseases [5,8].
• Key genes include MAP3Ks, MAP2Ks, MAPKs (p38, JNK), and phosphatases such as DUSP14 that modulate pathway output.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of this pathway in disease contexts [1,5].
Description
The stress-activated MAPK cascade is a central signaling pathway that cells use to respond to a wide range of environmental insults, including osmotic stress, oxidative stress, UV radiation, and inflammatory cytokines [1,4]. This cascade ultimately leads to the activation of p38 MAPK and JNK, which in turn phosphorylate transcription factors and other effectors to coordinate cellular stress responses [3,8]. The Gene Ontology term GO:0032874, positive regulation of stress-activated MAPK cascade, captures any process that enhances the activation or output of this signaling module. Understanding this term is critical because aberrant stress-activated MAPK signaling contributes to numerous pathologies, from cancer to neurodegenerative disorders [5,8]. Researchers studying this process need reliable tools to manipulate and measure pathway activity, making it a prime target for CRISPR-based functional genomics [1,5].
positive regulation of stress-activated MAPK cascade At A Glance
| GO ID | GO:0032874 |
|---|---|
| GO term | positive regulation of stress-activated MAPK cascade |
| Ontology | biological_process |
| Synonym | activation of stress-activated MAPK cascade; positive regulation of p38 MAPK signaling; upregulation of stress-activated MAPK cascade |
| Major function | Enhances signal transduction through the stress-activated MAPK cascade, leading to increased p38/JNK activation |
| Related pathways | p38 MAPK signaling, JNK signaling, MAPKKK cascade |
| Key upstream regulators | MKK3/6, MKK4/7, ASK1, MLK3, TAK1 |
| Key downstream effectors | ATF2, c-Jun, p53, HSP27 |
| Disease relevance | Cancer, neurodegeneration, inflammatory diseases, metabolic stress |
What Is GO:0032874?
GO:0032874 is defined as any process that activates or increases the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade. In simpler terms, it covers all the molecular events that turn up the volume on the cellular stress-response signaling pathway, leading to greater activation of p38 and JNK MAP kinases and their downstream targets [1,3].
Why Is positive regulation of stress-activated MAPK cascade Important in Cell Biology?
Positive regulation of the stress-activated MAPK cascade is essential for cellular adaptation to environmental stress and for maintaining homeostasis. Dysregulation of this process is linked to a broad spectrum of human diseases, including cancer, where stress-activated MAPKs can promote survival or apoptosis depending on context, and neurodegenerative conditions where aberrant JNK/p38 signaling contributes to neuronal death. Understanding the mechanisms that positively regulate this cascade is therefore critical for identifying therapeutic targets and for interpreting how cells integrate stress signals [1,3].
• Controls cellular responses to osmotic, oxidative, and inflammatory stress [1,4].
• Regulates cell survival, apoptosis, and differentiation decisions [3,8].
• Implicated in cancer progression and chemoresistance.
• Contributes to neurodegeneration through JNK-mediated neuronal death.
• Modulates immune responses and inflammation.
• Influences metabolic stress responses and iron homeostasis.
• Plays a role in cytokinesis and cell cycle regulation.
• Interacts with TOR complex 2 signaling to coordinate growth and stress responses.
• Target for therapeutic intervention in inflammatory and proliferative diseases.
• Provides a model for studying signal transduction amplification and feedback.
What Happens During positive regulation of stress-activated MAPK cascade?
Upstream activation of MAP3Ks
In simple terms: The stress signal first turns on a set of 'master switch' kinases called MAP3Ks.
In response to stress stimuli such as osmotic shock or inflammatory cytokines, upstream MAP3Ks including ASK1, MLK3, and TAK1 are activated through mechanisms involving protein-protein interactions and phosphorylation [3,8]. These MAP3Ks serve as the entry point for positive regulation, amplifying the initial stress signal.
Phosphorylation of MAP2Ks
In simple terms: The master switches then activate the next tier of kinases, the MAP2Ks.
Activated MAP3Ks phosphorylate and activate MAP2Ks such as MKK3/6 and MKK4/7. This step is a key point of positive regulation, as it determines the magnitude and duration of the downstream response. MKK3/6 preferentially activate p38, while MKK4/7 activate JNK.
Activation of p38 and JNK MAPKs
In simple terms: The MAP2Ks then add phosphate groups to p38 and JNK, turning them fully on.
MKK3/6 and MKK4/7 phosphorylate p38 and JNK on conserved threonine and tyrosine residues, leading to their catalytic activation. This dual phosphorylation is a hallmark of stress-activated MAPK cascade activation and is often used as a readout for pathway activity [3,8].
Downstream substrate phosphorylation and feedback
In simple terms: Once active, p38 and JNK modify many target proteins to change cell behavior.
Activated p38 and JNK phosphorylate transcription factors such as ATF2, c-Jun, and p53, as well as other effectors like HSP27. This leads to changes in gene expression, cell cycle progression, and survival [3,8]. Positive regulation can also involve suppression of negative feedback phosphatases like DUSP14, further enhancing pathway output.
Key Genes Involved in GO:0032874 positive regulation of stress-activated MAPK cascade
The following genes and proteins are core components or regulators of the positive regulation of the stress-activated MAPK cascade.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MAP3K5 (ASK1) | Upstream MAP3K that activates MKK4/7 and MKK3/6 | Central node in stress-induced apoptosis and inflammation |
| MAP3K11 (MLK3) | MAP3K that activates JNK and p38 pathways | Implicated in cancer and neurodegeneration |
| MAP3K7 (TAK1) | MAP3K activated by cytokines and stress | Key regulator of NF-kB and MAPK cross-talk |
| MAP2K3 (MKK3) | Phosphorylates and activates p38 MAPK | Specific activator of p38 alpha/beta |
| MAP2K6 (MKK6) | Phosphorylates and activates p38 MAPK | Critical for stress-induced p38 activation |
| MAP2K4 (MKK4) | Phosphorylates and activates JNK | Tumor suppressor in some contexts |
| MAP2K7 (MKK7) | Phosphorylates and activates JNK | Essential for JNK-mediated stress responses |
| MAPK14 (p38 alpha) | Stress-activated MAPK; phosphorylates transcription factors | Drug target for inflammatory diseases |
| MAPK8 (JNK1) | Stress-activated MAPK; regulates apoptosis and proliferation | Implicated in cancer and neurodegeneration |
| MAPK9 (JNK2) | Stress-activated MAPK; regulates apoptosis and proliferation | Isoform-specific functions in disease |
| DUSP14 | Phosphatase that negatively regulates JNK | Modulates stress-dependent c-Jun induction |
| JUN | Transcription factor phosphorylated by JNK | Key effector of stress-induced gene expression |
| ATF2 | Transcription factor phosphorylated by p38/JNK | Mediates stress-responsive transcription |
| TP53 | Tumor suppressor phosphorylated by p38/JNK | Links stress signaling to cell cycle arrest and apoptosis |
| HSPB1 (HSP27) | Small heat shock protein phosphorylated by p38 | Cytoprotective role in stress responses |
| BRD4 | Chromatin reader regulated by JNK during infection | Links stress signaling to transcription elongation |
| RICTOR | Component of TORC2 modulated by stress-activated MAPK | Connects stress signaling to growth control |
How Is positive regulation of stress-activated MAPK cascade Regulated?
The positive regulation of the stress-activated MAPK cascade is itself tightly regulated by multiple mechanisms. Negative feedback phosphatases such as DUSP14 can dephosphorylate JNK and dampen pathway output, and their suppression enhances stress-induced signaling. Cross-talk with other pathways, including the TOR complex 2 (TORC2) pathway, modulates the duration and intensity of stress-activated MAPK signaling. Additionally, scaffold proteins and subcellular localization of MAP3Ks contribute to signal specificity and amplification.
positive regulation of stress-activated MAPK cascade and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAPK8 (JNK1) | Cancer, neurodegeneration | Knockout and point-mutation cell lines |
| MAPK14 (p38 alpha) | Inflammatory diseases | Knock-in reporter for pathway activity |
| DUSP14 | Cancer (JNK-driven) | Overexpression and knockout models |
| JUN | Cancer, stress response | Knock-in of phospho-mutant |
| MAP3K5 (ASK1) | Neurodegeneration, inflammation | Knockout and conditional knock-in |
Cancer
Stress-activated MAPK signaling can promote tumor cell survival, proliferation, and chemoresistance. For example, the lincRNA JUNI regulates stress-dependent induction of c-Jun through modulation of the DUSP14-JNK axis, affecting cellular migration and survival in cancer cells. Targeting positive regulators of this cascade is a potential therapeutic strategy.
Neurodegeneration
Aberrant activation of JNK and p38 has been implicated in neuronal death in conditions such as Alzheimer's and Parkinson's diseases. Mitogen and stress-activated protein kinase 1 (MSK1), a downstream effector, negatively regulates hippocampal neurogenesis, suggesting that fine-tuning of stress-activated MAPK signaling is critical for brain function.
Inflammatory and metabolic diseases
p38 MAPK is a key mediator of inflammatory cytokine production, and its positive regulation contributes to chronic inflammatory diseases. Additionally, stress-activated MAPK signaling is involved in metabolic stress responses, including iron homeostasis through regulation of ferroportin 1.
From positive regulation of stress-activated MAPK cascade-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate stress-activated MAPK cascade? | Knockout cell line followed by stress stimulation and phospho-p38/JNK Western blot |
| What is the role of a specific phosphorylation site in MAP2K? | Point-mutation knock-in of phospho-deficient or phospho-mimetic residues |
| How does a disease-associated mutation affect pathway activity? | Knock-in of the mutation in a relevant cell line, then measure p38/JNK activation |
| Can a candidate gene enhance pathway output when overexpressed? | Overexpression cell line with inducible promoter, then stress response assay |
| What is the spatiotemporal dynamics of pathway activation? | Tagged knock-in of MAPK with fluorescent protein for live imaging |
| Which genes are essential for stress-induced transcription? | CRISPR library screening with stress-based selection |
How to Study the positive regulation of stress-activated MAPK cascade Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot (phospho-p38/JNK) | Activation status of MAPKs | Confirming pathway activation after stress |
| Luciferase reporter assay | Transcriptional output of stress-responsive promoters | Screening for pathway modulators |
| In vitro kinase assay | Catalytic activity of p38/JNK | Quantifying positive regulation |
| CRISPR knockout screen | Genes required for pathway activation | Discovery of novel regulators |
| CRISPR activation screen | Genes that enhance pathway activity | Identifying positive regulators |
| Phospho-flow cytometry | Single-cell activation of MAPKs | Heterogeneity studies |
| Live-cell imaging | Spatiotemporal dynamics of MAPK activation | Real-time pathway monitoring |
| RNA-seq | Transcriptional changes downstream of pathway | Global stress response profiling |
Phospho-protein analysis
Western blotting with antibodies against phospho-p38 and phospho-JNK is the standard method to measure activation of the stress-activated MAPK cascade. This approach is widely used to confirm positive regulation following genetic or chemical perturbations [3,8].
Transcriptional reporter assays
Luciferase reporters driven by stress-responsive promoters (e.g., AP-1 or ATF2 elements) can quantify downstream transcriptional output of the cascade. This is useful for high-throughput screening of regulators.
Kinase activity assays
In vitro kinase assays using recombinant p38 or JNK and substrate peptides measure the catalytic activity of these MAPKs directly. This provides a quantitative readout of positive regulation.
CRISPR screening
Genome-wide CRISPR knockout or activation screens coupled with stress challenges and phospho-flow cytometry can identify novel positive regulators of the stress-activated MAPK cascade [1,5].
How CRISPR Can Be Used to Study GO:0032874 positive regulation of stress-activated MAPK cascade
Knockout
CRISPR knockout of candidate positive regulators (e.g., MAP3Ks, MAP2Ks) followed by stress stimulation and phospho-MAPK analysis can definitively test whether a gene is required for pathway activation [1,3].
Point Mutation
Introducing point mutations (e.g., kinase-dead or phospho-site mutations) into MAP2Ks or MAPKs via CRISPR can dissect the specific residues required for positive regulation and downstream signaling [3,8].
Knock-in
Knock-in of fluorescent or epitope tags into endogenous MAPK genes allows real-time monitoring of pathway activation and localization without overexpression artifacts [1,5].
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can test whether increasing the level of a candidate gene is sufficient to enhance stress-activated MAPK signaling, identifying bona fide positive regulators.
How EDITGENE Supports positive regulation of stress-activated MAPK cascade Research
Researchers studying positive regulation of stress-activated MAPK cascade-related genes often need to determine whether a candidate gene is causally involved in pathway activation or if it merely correlates with stress responses. This requires precise genetic manipulation and quantitative readouts. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such studies.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of stress-activated MAPK cascade research.
Frequently Asked Questions About positive regulation of stress-activated MAPK cascade
What is GO:0032874?
GO:0032874 is the Gene Ontology term for positive regulation of stress-activated MAPK cascade, describing any process that increases the frequency, rate or extent of signal transduction through this pathway.
What genes are involved in positive regulation of stress-activated MAPK cascade?
Key genes include MAP3K5 (ASK1), MAP2K3/6 (MKK3/6), MAP2K4/7 (MKK4/7), MAPK14 (p38 alpha), MAPK8 (JNK1), and DUSP14 [3,8].
How is the stress-activated MAPK cascade activated?
It is activated by stress stimuli through sequential phosphorylation events: MAP3Ks activate MAP2Ks, which then phosphorylate p38 and JNK.
What diseases are associated with dysregulated stress-activated MAPK signaling?
Cancer, neurodegenerative diseases, inflammatory conditions, and metabolic stress disorders [5,7,8].
What methods are used to study positive regulation of stress-activated MAPK cascade?
Common methods include phospho-Western blotting, kinase assays, luciferase reporters, and CRISPR screens [1,3].
Can CRISPR be used to study this pathway?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the pathway [1,5].
What is the role of DUSP14 in this pathway?
DUSP14 is a phosphatase that negatively regulates JNK; its suppression enhances stress-dependent c-Jun induction.
How does TORC2 signaling interact with stress-activated MAPK?
The stress-activated MAPK pathway modulates TOR complex 2 signaling in fission yeast, linking stress responses to growth control.
What is the difference between p38 and JNK in this context?
Both are stress-activated MAPKs, but they are activated by different MAP2Ks (MKK3/6 for p38, MKK4/7 for JNK) and have distinct downstream targets.
Why is positive regulation of this cascade important for drug discovery?
Because aberrant activation contributes to cancer and inflammation, targeting positive regulators could provide therapeutic benefit [3,8].
Conclusion
GO:0032874, positive regulation of stress-activated MAPK cascade, represents a critical cellular process that amplifies stress signals to coordinate appropriate responses. Its dysregulation is linked to major human diseases, making it a fertile area for both basic and translational research [1,5,8]. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover new regulators and therapeutic targets within this pathway.
References
- 1. Madrid M et al.. 2021. Negative control of cytokinesis by stress-activated MAPK signaling.. Curr Genet 67(5):715-721 PMID: 33791858
- 2. Morigasaki S et al.. 2019. Modulation of TOR complex 2 signaling by the stress-activated MAPK pathway in fission yeast.. J Cell Sci 132(19) PMID: 31477575
- 3. Terada Y et al.. 1999. Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3/6-p38K and MKK1-MAPK.. Nephrol Dial Transplant 14 Suppl 1:45-7 PMID: 10048449
- 4. Sun W et al.. 2025. Activation of the stress-activated protein kinase JNK in response to herpes simplex virus-1 infection coordinates transition of BRD4 from chromosome association to transcription elongation.. J Biol Chem 301(9):110590 PMID: 40812420
- 5. Olateju OI et al.. 2021. Mitogen and Stress-activated Protein Kinase 1 Negatively Regulates Hippocampal Neurogenesis.. Neuroscience 452:228-234 PMID: 33246062
- 7. Oh CK et al.. 2016. Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS.. J Biol Chem 291(38):19858-72 PMID: 27445333
- 8. Kumar V et al.. 2024. The lincRNA JUNI regulates the stress-dependent induction of c-Jun, cellular migration and survival through the modulation of the DUSP14-JNK axis.. Oncogene 43(21):1608-1619 PMID: 38565943
